MONEY

ACELYRIN, INC. Announces Positive Results from Global Phase 3 Clinical Trial of Izokibep in Hidradenitis Suppurativa to be Highlighted in Late-Breaking Oral Presentation at EADV 2024

Tomas Kauer - ModeratorTomas Kauer - Moderator
Sep 19, 2024 - 20:00
ACELYRIN, INC. Announces Positive Results from Global Phase 3 Clinical Trial of Izokibep in Hidradenitis Suppurativa to be Highlighted in Late-Breaking Oral Presentation at EADV 2024
Read More

Tags:

Previous Article

Join Mobilicom's Exclusive Live Investor Webinar and Q&A Session on September 25

Next Article

Girard Sharp LLP and The Hall Firm, Ltd. Attorneys File Securities Class Action ...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

Renn Fund president and CEO acquires $2,645 in company stock

Renn Fund president and CEO acquires $2,645 in company ...

Tomas Kauer - Mode... Sep 28, 2024

At least 22 reported dead as storm John dissipates over Mexico

At least 22 reported dead as storm John dissipates over...

Tomas Kauer - Mode... Sep 29, 2024

Why Wells Fargo says investors have key decisions to make amid Fed easing cycle

Why Wells Fargo says investors have key decisions to ma...

Tomas Kauer - Mode... Sep 28, 2024